---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-026644"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:52:46.261908+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Incannex terminates $108.4M ATM sales agreement; announces enhanced Phase 2 dose-optimisation study

## Summary
- Mutually terminated Sales Agreement with Curvature Securities and A.G.P., effective March 11, 2026.
- Raised aggregate gross proceeds of ~$108.4M under the agreement prior to termination.
- Issued press release announcing enhanced Phase 2 dose-optimisation study (likely IHL-42X for OSA).
- Corporate presentation confirms cash position of ~$70M as of December 2025.
- Pipeline includes Phase 2/3 trials for OSA, GAD, and RA with positive data reported August 2025.

## SEC filing metadata
- accession: 0001213900-26-026644
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026644/0001213900-26-026644-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026644/ea0278415-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-026644
- JSON: https://secwatch.observer/filing/0001213900-26-026644.json
- Plain text: https://secwatch.observer/filing/0001213900-26-026644.txt

## Key facts
- Material Agreements
  Incannex Healthcare Inc. terminated Sales Agreement with Curvature Securities, LLC and A.G.P./Alliance Global Partners valued at Aggregate gross proceeds of approximately $108.4 million; termination at will with no penalty (effective 2026-03-11).
  - Action: termination
  - Agreement: atm program
  - Counterparty: Curvature Securities, LLC and A.G.P./Alliance Global Partners
  - Value: Aggregate gross proceeds of approximately $108.4 million; termination at will with no penalty
  - Effective: 2026-03-11
  source text: On March 11, 2026, the Company and the Sales Agents mutually agreed to terminate the Sales Agreement, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026644/0001213900-26-026644-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.